Document is current
Any future updates will be listed below
-
Authors
Bialonczyk, Urszula
Debowska, Malgorzata
Dai, Lu
Qureshi, Abdul Rashid
Bobrowski, Leon
Soderberg, Magnus
Lindholm, Bengt
Stenvinkel, Peter
Lukaszuk, Tomasz
Poleszczuk, Jan
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 13 May 2025
First Online: 20 May 2025
Declarations
:
: Peter Stenvinkel has a support from Bayer for conducting a randomized trial on testosterone supplementation in dialysis patients, participates in scientific advisory boards: Astra Zeneca, Glaxo, Vifor, Baxter, Fresenius, Invizius, and has payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Reata, Astra Zeneca, Baxter, Fresenius, Novo Nordisk, Astellas, Pfizer, Bayer; Magnus Soderberg is a full-time employee of AstraZeneca; Malgorzata Debowska has grant no 2018/31/D/ST7/03472 from National Science Center (Poland); Jan Poleszczuk has a grant grant No. 2018/31/D/ST7/03472 from National Science Center (Poland); Bengt Lindholm has a grant to Karolinska Institutet from Baxter Healthcare Corporation and was previously employed by Baxter Healthcare Corporation. He also has received stock or stock options from Baxter Healthcare Corporation; Urszula Bialonczyk – none; Lu Dai – none; Abdul Rashid Qureshi – none; Leon Bobrowski – none; Tomasz Lukaszuk – none.
